Abstract:Objective To investigate the clinical therapeutic effect of Oxaliplatin-containing chemotherapy combined with thermotherapy in the treatment of primary liver cancer. Methods Ninety cases of primary liver cancer were randomly divided into observation group and control group, with 45 cases in each group. The patients of the control group were given routine Oxaliplatin-containing chemotherapy, while the patients in the observation group were treated with thermotherapy based on the above treatment. The short-term efficacy, the level of pain relief, the changes of immune cells and the incidence of adverse reactions were compared between the two groups. Results The effective rate of the observation group was significantly higher than that of the control group (χ2 = 5.378, P < 0.05). The level of pain relief in the observation group was significantly better than that in the control group (χ2 = 18.519, P < 0.05). CD4+ T cells, CD4+/CD8+ and NK cells after treatment in the observation group were significantly higher than those in the control group (P < 0.05). The incidences of the adverse reactions of the digestive tract and liver function damage in the observation group were significantly lower than those in the control group (P < 0.05). Conclusions Thermotherapy combined with Oxaliplatin-containing chemotherapy has definite short-term curative effect in the treatment of primary liver cancer and can effectively alleviate cancer pain,immune injury and adverse reactions, therefore has clinical value.